TIBER CREEK GROUP for ASTRAZENECA
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Issues relating to Intellectual Property protections for Covid-19 treatments and vaccines.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHON JONES | — |
Environment/Superfund ENV
Issues related to sustainability of health care sector.
| Lobbyist | Covered position, as disclosed |
|---|---|
| COREY MALMGREN | — |
Medicare/Medicaid MMM
Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); Issues relating to Part D Pricing Reform; issues relating to Medicare Part D and Part B Pricing Reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHON JONES | — |
| COREY MALMGREN | — |
| TIMOTHY ROBINSON | — |
Health Issues HCR
S. 4446 - Modernizing Accelerated Approval Pathway Act of 2022; H.R. 6584 - DEPICT Act; S. 4348 - Food and Drug Administration Safety and Landmark Advancements Act of 2022; H.R. 7667 - Food and Drug Amendments of 2022; Consolidated Appropriations Act, 2023 (PL 117-328), Division FF, Title III - Food and Drug Administration, Subtitle B - Drugs and Biologics and Subtitle F, Chapter 1 - Clinical Trial Diversity and Modernization; Package Inserts/eLabeling Issues (H.R. 7559 - Prescription Information Modernization Act of 2022).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHON JONES | — |
| COREY MALMGREN | — |
| TIMOTHY ROBINSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.